Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | NR5A2 | O00482 | 1/20 | 1.00 |
| ▸ | NR5A1 | Q13285 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.88 |
| ▸ | FABP3 | P05413 | 1/20 | 0.78 |
| ▸ | RECQL | P46063 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.66 |
| ▸ | PTAFR | P25105 | 1/20 | 0.66 |
| ▸ | HTR1D | P28221 | 1/20 | 0.66 |
| ▸ | HTR2C | P28335 | 1/20 | 0.66 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.66 |
| ▸ | DRD3 | P35462 | 1/20 | 0.66 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.66 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.63 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.63 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | GMNN | O75496 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL235513 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL234621 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL233979 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL234757 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL22693933 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL17165029 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL237094 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL2135188 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL233582 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL235645 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1079 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746923-A2 | DELIVERY SYSTEM COMPRISING LIPID OR POLYMERIC NANOPARTICLES COMPRISING THYROID HORMONES | FONDAZIONE RICCARDO TERZI E SILVIO ALBINI (IT) | 2026-05-27 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20250090597-A1 | AIRWAY BASAL CELL ENGRAFTMENT METHODS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-03-20 | — | — | US | claimed |
| WO-2025030143-A1 | AIRWAY BASAL CELL ENGRAFTMENT METHODS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2025017370-A2 | DELIVERY SYSTEM COMPRISING LIPID OR POLYMERIC NANOPARTICLES COMPRISING THYROID HORMONES | FONDAZIONE RICCARDO TERZI E SILVIO ALBINI (IT) | 2025-01-23 | — | — | WO | claimed |
| US-20240358939-A1 | INTERNAL CANNULA MOUNTED NEBULIZER | VAPOTHERM, INC. | 2024-10-31 | — | — | US | claimed |
| US-20240325610-A1 | DRUG COATING, DRUG-COATED BALLOON AND PREPARATION METHOD THEREOF | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. (CN) | 2024-10-03 | — | — | US | claimed |
| CN-118217244-A | Mitochondrial targeting liposome based on membrane fusion and preparation method and application thereof | 中国科学院化学研究所 | 2024-06-21 | — | — | CN | claimed |
| EP-4321183-A1 | DRUG COATING, DRUG COATING SACCULE AND METHOD FOR PREPARING SAME | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. (CN) | 2024-02-14 | — | — | EP | claimed |
| US-20220313713-A1 | VAPORIZABLE PSYCHOACTIVE ALKALOID COMPOSITION AND PREPARATION THEREOF | PSILO SCIENTIFIC LTD. (CA) | 2022-10-06 | — | — | US | claimed |
| CN-1543337-A | Expandable gastric retention device | ���ո����ɸߵȽ�����ίԱ�������� | 2004-11-03 | — | — | CN | claimed |
| EP-1440083-A2 | MOLECULES | Medical Research Council (GB) | 2004-07-28 | — | — | EP | claimed |
| EP-1416914-A1 | EXPANDABLE GASTRIC RETENTION DEVICE | The State of Oregon acting by and through The State Board of Higher Education on behalf of Oregon State University (US) | 2004-05-12 | — | — | EP | claimed |
| CN-1450914-A | Preparation of clear aqueous solution dosage form containing bile acid | SEO-HONG YOO (US) | 2003-10-22 | — | — | CN | claimed |
| US-20030186933-A1 | Preparation of aqueous clear solution dosage forms with bile acids | YOO SEO HONG (US) | 2003-10-02 | — | — | US | claimed |
| WO-2003035679-A2 | MOLECULES | MEDICAL RESEARCH COUNCIL (GB) | 2003-05-01 | — | — | WO | claimed |
| WO-2003015745-A1 | EXPANDABLE GASTRIC RETENTION DEVICE | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 2003-02-27 | — | — | WO | claimed |
| EP-1255566-A2 | PREPARATION OF AQUEOUS CLEAR SOLUTION DOSAGE FORMS WITH BILE ACIDS | Yoo, Seo Hong (US) | 2002-11-13 | — | — | EP | claimed |
| US-20020031558-A1 | Preparation of aqueous clear solution dosage forms with bile acids | YOO SEO HONG (US) | 2002-03-14 | — | — | US | claimed |
| WO-2001056547-A2 | PREPARATION OF AQUEOUS CLEAR SOLUTION DOSAGE FORMS WITH BILE ACIDS | YOO SEO HONG (US) | 2001-08-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186933-A1 | Preparation of aqueous clear solution dosage forms with bile acids | SLC10A2, ABCB11, SLC10A1 | SMN1; SMN2 985/4885NR5A2 3831/4885NR5A1 1154/4885 |
| US-20250090597-A1 | AIRWAY BASAL CELL ENGRAFTMENT METHODS | KRT18, MUC1, TUBB3 | SMN1; SMN2 1615/4885NR5A2 2635/4885NR5A1 1566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.